Almirall S.A. Logo

Almirall S.A.

A global biopharmaceutical company developing innovative medical solutions for skin health.

ALM | MC

Overview

Corporate Details

ISIN(s):
ES0157097017
LEI:
95980020140005007996
Country:
Spain
Address:
Ronda General Mitre 151, 08022 Barcelona
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Almirall S.A. is a global biopharmaceutical company focused on medical dermatology. Founded in 1944, the company researches, develops, manufactures, and markets medical solutions for skin health. It partners with healthcare professionals to address the needs of patients with various dermatological conditions. Almirall's mission is to apply science to provide innovative treatments that improve patients' lives. The company maintains a global presence with affiliates in Europe and the United States, and its products are available in over 100 countries.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-12 07:33
Notice of Dividend Amount
Información sobre el calendario del dividendo
Spanish 104.4 KB
2025-05-12 07:23
Share Issue/Capital Change
Información sobre dividendos
Spanish 188.2 KB
2025-05-12 07:15
Post-Annual General Meeting Information
Acuerdos adoptados por el Consejo de Administración
Spanish 105.9 KB
2025-05-12 07:04
Post-Annual General Meeting Information
Acuerdos adoptados por la Junta General de Accionistas 2025
Spanish 182.9 KB
2025-05-12 06:57
Investor Presentation
Almirall remite presentación sobre los resultados del primer trimestre de 2025 …
Spanish 1.3 MB
2025-05-12 06:51
Report Publication Announcement
Almirall realizará una presentación vía webcast para explicar los Resultados de…
Spanish 101.3 KB
2025-05-12 00:00
Post-Annual General Meeting Information
Acuerdos adoptados por la Junta General de Accionistas 2025
Spanish 182.9 KB
2025-04-09 11:58
Transaction in Own Shares
Operaciones del contrato de liquidez durante el primer trimestre de 2025
English 187.4 KB
2025-04-01 13:17
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025 -…
Spanish 279.9 KB
2025-04-01 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025 -…
Spanish 279.9 KB
2025-03-31 17:58
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025
Spanish 141.0 KB
2025-03-31 00:00
Report Publication Announcement
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025
Spanish 141.0 KB
2025-03-06 07:28
Board/Management Information
Almirall anuncia el plan de transición del CFO
Spanish 72.6 KB
2025-02-24 06:43
Earnings Release
La sociedad remite presentación sobre los resultados del ejercicio 2024
Spanish 1.3 MB
2025-02-24 06:39
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 510.9 KB

Automate Your Workflow. Get a real-time feed of all Almirall S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Almirall S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden BIOVIC

Talk to a Data Expert

Have a question? We'll get back to you promptly.